세계의 특수 제네릭 주사제 시장 규모 : 종류별(의약품, 생물제제), 용도별(종양, 순환기, 감염증, 중추신경계, 자가면역질환, 기타), 지역별 예측(2022-2028년)

Global Specialty Injectable Generics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Specialty Injectable Generics are drug therapies used for the treatment of chronic conditions that need injection, infusion, or inhalation and are sold as generics.. It includes biologics used in the treatment of a variety of drugs and has the same active ingredients as branded versions, although the inactive contents of the medications can vary. Specialty Injectable Generics are less expensive as compared to traditional drugs and growing number of patents set to expire have led to the adoption of Specialty Injectable Generics across the forecast period. For Instance: as per Statista in 2021, the global specialty generics market was valued at roughly 45 billion dollars in 2018, and it is predicted to grow to nearly 90 billion dollars by 2024. Due to patent expiration, the industry is anticipated to lose 19 billion dollars in prescription medicine sales worldwide by 2022. Following the expiration of a patent, other businesses are permitted to produce less expensive generic versions of the original branded drug. Also, as the key market participants are launching new products and illness prevalence is on the rise are likely to increase the market growth during the forecast period. However, manufacturing biologics and generic injectable is an expensive and difficult operation that may impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Specialty Injectable Generics Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of patents set to expire. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as key market participants launching new products and rising illness prevalence would create lucrative growth prospects for the Specialty Injectable Generics Market across Asia-Pacific region.

Major Market players included in this report are:

Baxter

Cipla Inc.

Dr. Reddy's Laboratories Ltd

Fresenius Kabi

Hikma Pharmaceuticals PLC

Novartis AG

Par Pharmaceutical

Pfizer Inc

SAGENT Pharmaceuticals

Sun Pharmaceutical Industries Ltd.

The objective of the study is to define Market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the Market. Additionally, the report shall also incorporate available opportunities in micro Markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the Market are explained below:

By Type:

Drugs

Biologics

By Application:

Oncology

Cardiovascular

Infectious Diseases

Central Nervous Systems

Autoimmune Disorders

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Specialty Injectable Generics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
  • 1.2.1. Specialty Injectable Generics Market, by Region, 2020-2028 (USD Billion)
  • 1.2.2. Specialty Injectable Generics Market, by Type, 2020-2028 (USD Billion)
  • 1.2.3. Specialty Injectable Generics Market, by Application, 2020-2028 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Specialty Injectable Generics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Specialty Injectable Generics Market Dynamics

• 3.1. Specialty Injectable Generics Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Less expensive as compared to traditional drugs
    • 3.1.1.2. Growing number of patents are set to expire
  • 3.1.2. Market Challenges
    • 3.1.2.1. Manufacturing biologics and generic injectables is an expensive and difficult operation
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Key Market participants are launching new products
    • 3.1.3.2. Illness prevalence is on the rise

Chapter 4. Global Specialty Injectable Generics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Specialty Injectable Generics Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Specialty Injectable Generics Market by Type, Performance - Potential Analysis
• 6.3. Global Specialty Injectable Generics Market Estimates & Forecasts by Type, 2018-2028 (USD Billion)
• 6.4. Specialty Injectable Generics Market, Sub Segment Analysis
  • 6.4.1. Drugs
  • 6.4.2. Biologics

Chapter 7. Global Specialty Injectable Generics Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Specialty Injectable Generics Market by Application, Performance - Potential Analysis
• 7.3. Global Specialty Injectable Generics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
• 7.4. Specialty Injectable Generics Market, Sub Segment Analysis
  • 7.4.1. Oncology
  • 7.4.2. Cardiovascular
  • 7.4.3. Infectious Diseases
  • 7.4.4. Central Nervous Systems
  • 7.4.5. Autoimmune Disorders
  • 7.4.6. Others

Chapter 8. Global Specialty Injectable Generics Market, Regional Analysis

• 8.1. Specialty Injectable Generics Market, Regional Market Snapshot
• 8.2. North America Specialty Injectable Generics Market
  • 8.2.1. U.S. Specialty Injectable Generics Market
    • 8.2.1.1. Type breakdown estimates & forecasts, 2018-2028
    • 8.2.1.2. Application breakdown estimates & forecasts, 2018-2028
  • 8.2.2. Canada Specialty Injectable Generics Market
• 8.3. Europe Specialty Injectable Generics Market Snapshot
  • 8.3.1. U.K. Specialty Injectable Generics Market
  • 8.3.2. Germany Specialty Injectable Generics Market
  • 8.3.3. France Specialty Injectable Generics Market
  • 8.3.4. Spain Specialty Injectable Generics Market
  • 8.3.5. Italy Specialty Injectable Generics Market
  • 8.3.6. Rest of Europe Specialty Injectable Generics Market
• 8.4. Asia-Pacific Specialty Injectable Generics Market Snapshot
  • 8.4.1. China Specialty Injectable Generics Market
  • 8.4.2. India Specialty Injectable Generics Market
  • 8.4.3. Japan Specialty Injectable Generics Market
  • 8.4.4. Australia Specialty Injectable Generics Market
  • 8.4.5. South Korea Specialty Injectable Generics Market
  • 8.4.6. Rest of Asia Pacific Specialty Injectable Generics Market
• 8.5. Latin America Specialty Injectable Generics Market Snapshot
  • 8.5.1. Brazil Specialty Injectable Generics Market
  • 8.5.2. Mexico Specialty Injectable Generics Market
• 8.6. Rest of The World Specialty Injectable Generics Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Baxter
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Cipla Inc.
  • 9.2.3. Dr. Reddy's Laboratories Ltd
  • 9.2.4. Fresenius Kabi
  • 9.2.5. Hikma Pharmaceuticals PLC
  • 9.2.6. Novartis AG
  • 9.2.7. Par Pharmaceutical
  • 9.2.8. Pfizer Inc
  • 9.2.9. SAGENT Pharmaceuticals
  • 9.2.10. Sun Pharmaceutical Industries Ltd.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption